Related Experiment Videos
Microalbuminuria
M Marre1, B Bouhanick, G Berrut
1University Hospital, Angers, France.
Abstract:
Microalbuminuria indicates slightly elevated urinary albumin excretion. In most cases, microalbuminuria is of glomerular origin and indicates initial glomerulosclerosis. Microalbuminuria has a high predictive value for nephropathy in insulin-dependent diabetes subjects and for premature mortality due to cardiovascular disease in non-insulin-dependent diabetes subjects and in the general population. All cardiovascular risk factors can be determinants for microalbuminuria constitution, especially the genetic determinants of these risk factors. Thus, microalbuminuria can be an indicator to summarize renal or cardiovascular risk, or both, in various populations. Treatment interventions were performed using microalbuminuria as the endpoint. So far, the most convincing results were obtained with angiotensin I-converting enzyme inhibitors to prevent nephropathy in insulin-dependent diabetes subjects.
Insights
Microalbuminuria, an early sign of kidney damage, predicts cardiovascular disease and kidney disease. Angiotensin-converting enzyme inhibitors show promise in preventing diabetic nephropathy.
Area of Science:
- Nephrology
- Cardiology
- Endocrinology
Background:
- Microalbuminuria signifies elevated urinary albumin excretion, often indicating early glomerulosclerosis.
- It serves as a crucial predictor for diabetic nephropathy and premature cardiovascular mortality.
Purpose of the Study:
- To highlight microalbuminuria as a key indicator of combined renal and cardiovascular risk.
- To review treatment interventions targeting microalbuminuria.
Main Methods:
- Literature review and analysis of studies using microalbuminuria as an endpoint.
- Examination of risk factors, including genetic determinants, contributing to microalbuminuria.
Main Results:
- Microalbuminuria is a strong predictor of nephropathy in insulin-dependent diabetes.
- It also predicts cardiovascular mortality in non-insulin-dependent diabetes and the general population.
- Angiotensin-converting enzyme inhibitors demonstrated efficacy in preventing nephropathy.
Conclusions:
- Microalbuminuria is a valuable biomarker for summarizing renal and cardiovascular risk across diverse populations.
- Early identification and intervention are crucial for managing conditions associated with microalbuminuria.